Abnormal cholinergic and GABAergic vascular innervation in the hypothalamic arcuate nucleus of obese tub/tub mice

被引:16
作者
Bäckberg, M [1 ]
Meister, B [1 ]
机构
[1] Karolinska Inst, Retzius Lab, Dept Neurosci, SE-17177 Stockholm, Sweden
关键词
acetylcholine; blood vessel; body weight; food intake; tubby; VAChT;
D O I
10.1002/syn.20024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tubby and tubby-like proteins (TULPs) are encoded by members of a small gene family. An autosomal recessive mutation in the mouse tub gene leads to blindness, deafness, and maturity-onset obesity. The mechanisms by which the mutation causes the obesity syndrome has not been established. We compared obese tub/tub mice and their lean littermates in order to find abnormalities within the mediobasal hypothalamus, a region intimately associated with the regulation of body weight. Using an antiserum to the vesicular acetylcholine transporter (VAChT), a marker for cholinergic neurons, many unusually large VAChT-immunoreactive (-ir) nerve terminals, identified by colocalization with the synaptic vesicle protein synaptophysin, were demonstrated in the hypothalamic arcuate nucleus of obese tub/tub mice. Double-labeling showed that VAChT-ir nerve endings also contained glutamic acid decarboxylase (GAD), a marker for gamma-aminobutyric acid (GABA) neurons. The VAChT- and GAD-ir nerve terminals were in close contact with blood vessels, identified with antisera to platelet endothelial cell adhesion molecule-1 (PECAM; also called CD31), laminin, smooth muscle actin (SMA), and glucose transporter-1 (GLUT1). Such large cholinergic and GABAergic nerve terminals surrounding blood vessels were not seen in the arcuate nucleus of lean tub/ + mice. The presence of abnormal cholinergic/GABAergic vascular innervation in the arcuate nucleus suggests that alterations in this region, which contains neurons that receive information from the periphery and which relays information about the energy status to other parts of the brain, may be central in the development of the obese phenotype in animals with an autosomal recessive mutation in the tub gene. Synapse 52:245-257, 2004. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:245 / 257
页数:13
相关论文
共 67 条
[1]   Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells [J].
Abbruscato, TJ ;
Lopez, SP ;
Mark, KS ;
Hawkins, BT ;
Davis, TP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (12) :2525-2538
[2]  
Arvidsson U, 1997, J COMP NEUROL, V378, P454
[3]   Distribution of muscarinic receptors on the endothelium of cortical vessels in the rat brain [J].
Badaut, J ;
Moro, V ;
Seylaz, J ;
Lasbennes, F .
BRAIN RESEARCH, 1997, 778 (01) :25-33
[4]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[5]   Implication of tubby proteins as transcription factors by structure-based functional analysis [J].
Boggon, TJ ;
Shan, WS ;
Santagata, S ;
Myers, SC ;
Shapiro, L .
SCIENCE, 1999, 286 (5447) :2119-2125
[6]  
Brenman JE, 1998, J NEUROSCI, V18, P8805
[7]   Multiple nicotinic acetylcholine receptor α-subunits are expressed in the arterial system of the rat [J].
Brüggmann, D ;
Lips, KS ;
Pfeil, U ;
Haberberger, RV ;
Kummer, W .
HISTOCHEMISTRY AND CELL BIOLOGY, 2002, 118 (06) :441-447
[8]   FAT (FAT) AND TUBBY (TUB) - 2 AUTOSOMAL RECESSIVE MUTATIONS CAUSING OBESITY SYNDROMES IN THE MOUSE [J].
COLEMAN, DL ;
EICHER, EM .
JOURNAL OF HEREDITY, 1990, 81 (06) :424-427
[9]   Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight [J].
Collin, M ;
Bäckberg, M ;
Ovesjö, ML ;
Fisone, G ;
Edwards, RH ;
Fujiyama, F ;
Meister, B .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (05) :1265-1278
[10]   CHOLINERGIC AND VASOACTIVE INTESTINAL POLYPEPTIDERGIC INNERVATION OF THE CEREBRAL-ARTERIES [J].
DAUPHIN, F ;
MACKENZIE, ET .
PHARMACOLOGY & THERAPEUTICS, 1995, 67 (03) :385-417